The Latin America, Middle East and Africa Burn Ointment Market would witness market growth of 6.6% CAGR during the forecast period (2020-2026). The hydrocolloid dressing is a burn care accessory that have inner gel-forming agents and outer flexible water-resistant layer that is used for moderate burn wounds. Burn care products & accessories also include burn dressings, moist burn pads, water gel spray, hydrogel, Non-adherent pads, and hydrocolloid, collagen, and alginate dressings. For higher degree burns treatment wound dressing, medication, therapy, and surgery are done to control pain, prevent infection, and removing dead cells.
The advancement in technology, favorable reimbursement policies, and the increasing incidence of burn cases are the major factors responsible for market growth. In addition to it, increasing awareness about various treatment options and the availability of cost-effective ointment is also expected to fuel the market over the forecast period.
The risk of hospital-acquired infections (HAI) is one of the major challenges that is faced by patients with burn injuries. The highest revenue in the burn injury treatment market is generated from hospitals. The healthcare providers in hospitals and clinics are providing topical treatments in order to reduce the incidences of hospital-acquired infections.
Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Burn Ointment Market in LAMEA is expected to register a CAGR of 6.6% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
By Depth of Burn
By Product
By End Use
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 